Lillys Mounjaro (Tirzepatide), a GIP/GLP-1 Dual Agonist, Demonstrated Cardiovascular Protection in Landmark Head-to-Head Trial, Reinforcing Its Benefit in Patients with Type 2 Diabetes and Heart Disease (Eli Lilly and Company, accessed 19 August 2025)
Hn th na, Collagen cn c xem l thn dc gip ci lo hon ng gip cho ln da ca bn cng, sng mn v trn y sc sng
Compared with DPP-4i users, GLP-1 RA users were younger (mean age 56.1 vs 62.3 years), had a higher body mass index (36.5 vs 32.1 kg/m), and were less likely to be male (45.2% vs 50.4%)
SAFE HARBOR ACT: Forward-looking statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended
4) and the relationship between precise patient-specific control of activation level and CAR T cell functionality 20 , we hypothesized that rapamycin may have a greater effect on decreasing the activation of STR compared to LTR CAR T cells
Gentile M, Offidani M, Vigna E, Corvatta L, Recchia AG, Morabito L, Morabito F, Gentili S (2015) Ixazomib for the treatment of multiple myeloma
